Title:
USE OF ATTENUATED STRAINS OF TOXOPLASMA FOR THE PREVENTION OR TREATMENT OF CRYPTOSPORIDIOSIS
Document Type and Number:
WIPO Patent Application WO/2014/020290
Kind Code:
A3
Abstract:
The present invention concerns strains of Sarcocystidae chosen from Toxoplasma spp or Neospora spp isolated from the natural environment of same and having an immunostimulating effect for the use of same in the prevention or treatment, in a mammal, of a pathology associated with an apicomplexan of the Cryptosporidium family.
More Like This:
Inventors:
GNAHOUI-DAVID AUDREY (FR)
LAURENT FABRICE (FR)
MEVELEC MARIE-NOËLLE (FR)
SECHE EDOUARD (FR)
LAURENT FABRICE (FR)
MEVELEC MARIE-NOËLLE (FR)
SECHE EDOUARD (FR)
Application Number:
PCT/FR2013/051876
Publication Date:
July 17, 2014
Filing Date:
August 02, 2013
Export Citation:
Assignee:
VITAMFERO
AGRONOMIQUE INST NAT RECH (FR)
UNIV FRANCOIS RABELAIS DE TOURS (FR)
AGRONOMIQUE INST NAT RECH (FR)
UNIV FRANCOIS RABELAIS DE TOURS (FR)
International Classes:
A61K39/012; A61K39/39
Domestic Patent References:
| WO2011011725A2 | 2011-01-27 |
Other References:
PENARETE-VARGAS DIANA MARCELA ET AL: "Protection against Lethal Neospora caninum Infection in Mice Induced by Heterologous Vaccination with a mic1 mic3 Knockout Toxoplasma gondii Strain", INFECTION AND IMMUNITY, vol. 78, no. 2, February 2010 (2010-02-01), pages 651 - 660, XP002696799
Attorney, Agent or Firm:
GROSSET-FOURNIER, Chantal et al. (Paris, Paris, FR)
Download PDF:
Previous Patent: METHOD AND DEVICE FOR IDENTIFYING MATERIALS IN A SCENE
Next Patent: MUTANT STRAINS OF NEOSPORA AND USES THEREOF
Next Patent: MUTANT STRAINS OF NEOSPORA AND USES THEREOF